Evaluation of Recombinant Factor VIIa Treatment for Massive Hemorrhage in Patients with Multiple Traumas

BACKGROUND: Recent studies and case reports have shown that recombinant factor VIIa (rFVIIa) treatment is effective for reversing coagulopathy and reducing blood transfusion requirements in trauma patients with life-threatening hemorrhage. The purpose of this study is to evaluate the effect of rFVII...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Young Rae, Cho, Suck Ju, Yeom, Seok Ran, Chang, Chulhun L., Lee, Eun Yup, Son, Han Chul, Kim, Hyung Hoi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289780/
https://www.ncbi.nlm.nih.gov/pubmed/22389882
http://dx.doi.org/10.3343/alm.2012.32.2.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289780/
https://www.ncbi.nlm.nih.gov/pubmed/22389882
http://dx.doi.org/10.3343/alm.2012.32.2.145

Ejemplares similares